Listeria Prompts FDA Partial Hold On Cancer Drug Trial
Cancer immunotherapy developer Aduro Biotech Inc. said Monday that the U.S. Food and Drug Administration has put a partial hold on a clinical trial for one of its drugs after a...To view the full article, register now.
Already a subscriber? Click here to view full article